Literature DB >> 9698540

In vitro analysis of the dominant negative effect of p53 mutants.

P Chène1.   

Abstract

Missense mutations of the p53 tumour suppressor gene induce the formation of proteins with an altered affinity for DNA. These mutant proteins have either a wild-type or a mutant conformation. It has been established that, on association with wild-type protein, molecules with mutant conformation can drive the wild-type p53 into a mutant conformation. It is shown here that mutant proteins with a wild-type conformation can also inactivate wild-type p53 upon oligomerisation. The dominant negative activity of these mutants depends on their ability to bind to DNA. The less a mutant protein binds to DNA, the more it is dominant negative. Their dominant negative activity is also dependent on the DNA-binding site. The binding of wild-type to a low-affinity DNA element is more easily inactivated by a dominant negative mutant than its binding to a high-affinity DNA-binding site. Copyright 1998 Academic Press

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9698540     DOI: 10.1006/jmbi.1998.1897

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Authors:  D Matas; A Sigal; P Stambolsky; M Milyavsky; L Weisz; D Schwartz; N Goldfinger; V Rotter
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

Review 2.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 3.  Chromosome instability and deregulated proliferation: an unavoidable duo.

Authors:  Courtney H Coschi; Frederick A Dick
Journal:  Cell Mol Life Sci       Date:  2012-01-06       Impact factor: 9.261

4.  Li-fraumeni syndrome.

Authors:  David Malkin
Journal:  Genes Cancer       Date:  2011-04

5.  Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding.

Authors:  GuoZhen Wang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

Review 6.  The rebel angel: mutant p53 as the driving oncogene in breast cancer.

Authors:  Dawid Walerych; Marco Napoli; Licio Collavin; Giannino Del Sal
Journal:  Carcinogenesis       Date:  2012-07-20       Impact factor: 4.944

7.  Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of IκBα expression.

Authors:  Laura Marruecos; Joan Manils; Cristina Moreta; Diana Gómez; Ingrid Filgaira; Anna Serafin; Xavier Cañas; Lluís Espinosa; Concepció Soler
Journal:  Cell Death Dis       Date:  2021-04-06       Impact factor: 8.469

8.  A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.

Authors:  Yunguang Sun; Carey Jeanne Myers; Adam Paul Dicker; Bo Lu
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

9.  Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1.

Authors:  Xin Tong; Dandan Xu; Rama K Mishra; Ryan D Jones; Leyu Sun; Gary E Schiltz; Jie Liao; Guang-Yu Yang
Journal:  J Biol Chem       Date:  2020-11-21       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.